WEBVTT 00:00:00.000 --> 00:00:02.299 You know, have you ever really stopped to think 00:00:02.299 --> 00:00:04.599 about the trust we place in medical devices? 00:00:04.799 --> 00:00:07.280 I mean, everything from like a simple elastic 00:00:07.280 --> 00:00:10.240 bandage you wrap around your ankle to these incredibly 00:00:10.240 --> 00:00:13.179 complex heart devices implanted inside us. We 00:00:13.179 --> 00:00:15.880 just sort of expect them to work, to be safe, 00:00:16.379 --> 00:00:19.899 to be effective. But how do we actually know? 00:00:19.980 --> 00:00:22.519 How is that trust truly earned? Yeah, definitely 00:00:22.519 --> 00:00:26.000 not magic. Yeah. It's a profound, really multi 00:00:26.000 --> 00:00:28.820 -layered regulatory system. specifically designed, 00:00:28.879 --> 00:00:30.879 you know, for your safety. Exactly. And that's 00:00:30.879 --> 00:00:32.719 what we're here to do today, right? And that's 00:00:32.719 --> 00:00:35.079 Deep Dive. Precisely. We want to pull back the 00:00:35.079 --> 00:00:36.840 curtain on that system. We're going to unpack 00:00:36.840 --> 00:00:39.280 the FDA's whole approach to classifying medical 00:00:39.280 --> 00:00:42.159 devices. And then kind of walk through the rigorous 00:00:42.159 --> 00:00:44.179 pathways manufacturers have to follow to get 00:00:44.179 --> 00:00:46.619 these devices actually cleared or approved for 00:00:46.619 --> 00:00:48.359 market. Yeah, we're aiming to cut through some 00:00:48.359 --> 00:00:51.380 of that complexity, demystify things like substantial 00:00:51.380 --> 00:00:53.899 equivalence, and really detail the different 00:00:53.899 --> 00:00:57.619 routes, you know, the 510K, the PMA, de novo 00:00:57.619 --> 00:01:00.840 pathway. The goal is for you, our listener, to 00:01:00.840 --> 00:01:03.460 get a really clear understanding of the scrutiny 00:01:03.460 --> 00:01:05.900 these devices go through and why it matters so 00:01:05.900 --> 00:01:09.280 much. Okay, so it's incredible how varied medical 00:01:09.280 --> 00:01:11.989 devices are. But the FDA doesn't treat them all 00:01:11.989 --> 00:01:13.769 the same, which makes sense. It's all based on 00:01:13.769 --> 00:01:15.590 risk, isn't it? How does that breakdown work? 00:01:15.730 --> 00:01:18.090 It absolutely is. The key thing to grasp is this 00:01:18.090 --> 00:01:21.030 tiered risk -based classification system. Basically, 00:01:21.150 --> 00:01:22.909 devices fall into class one, class two, or class 00:01:22.909 --> 00:01:25.549 three. And it's simple logic. The higher the 00:01:25.549 --> 00:01:27.909 class, the greater the potential risk to patients. 00:01:28.549 --> 00:01:30.750 And therefore, the tougher their regulatory controls. 00:01:30.849 --> 00:01:32.870 It's about matching the oversight to the potential 00:01:32.870 --> 00:01:34.689 harm. OK, let's start at the bottom then. Class 00:01:34.689 --> 00:01:37.500 one, low risk. What does that entail? All right, 00:01:37.620 --> 00:01:39.439 class I devices are the lowest risk category. 00:01:39.719 --> 00:01:41.819 They're subject to what the FDA calls general 00:01:41.819 --> 00:01:44.819 controls. Think of general controls as like. 00:01:45.019 --> 00:01:47.299 the universal baseline rules. They apply to all 00:01:47.299 --> 00:01:49.840 devices. They cover things like the quality system 00:01:49.840 --> 00:01:52.980 regulation, that's 21 CFR part 820, basically 00:01:52.980 --> 00:01:55.560 the FDA's rule book for how manufacturers design, 00:01:55.739 --> 00:01:58.459 build, and monitor devices. Plus, strict rules 00:01:58.459 --> 00:02:02.040 for labeling, 21 CFR part 801, and reporting 00:02:02.040 --> 00:02:04.159 serious problems, which is medical device reporting 00:02:04.159 --> 00:02:06.540 part 803. Okay, baseline rules. And what kind 00:02:06.540 --> 00:02:08.719 of things fall into class one? Give us some examples. 00:02:08.800 --> 00:02:10.889 Sure. Often things you might not even think of 00:02:10.889 --> 00:02:13.469 as heavily regulated. We're talking tongue depressors, 00:02:13.689 --> 00:02:15.830 surgical scissors, elastic bandages, pretty common 00:02:15.830 --> 00:02:18.110 stuff. But also things like pipe hitting systems 00:02:18.110 --> 00:02:20.729 for labs, anesthesia breathing circuits, even 00:02:20.729 --> 00:02:23.330 x -ray film. Huh. Yeah, and many of these Class 00:02:23.330 --> 00:02:25.669 I devices are actually exempt from needing that 00:02:25.669 --> 00:02:27.710 pre -market notification, the 510k we mentioned. 00:02:28.449 --> 00:02:30.370 But, and this is important, they're not off the 00:02:30.370 --> 00:02:33.129 hook completely. They still need to follow parts 00:02:33.129 --> 00:02:36.650 of the quality system rules. Specifically, section 00:02:36.650 --> 00:02:41.669 820 .1A0 for general records and 820 .198 for 00:02:41.669 --> 00:02:44.509 complaint files. Some also need design controls 00:02:44.509 --> 00:02:47.150 and post -market vigilance. Wow, okay. So even 00:02:47.150 --> 00:02:48.949 for a simple tongue depressor, there's still 00:02:48.949 --> 00:02:51.650 oversight and a paper trail. Exactly. Even the 00:02:51.650 --> 00:02:53.669 simplest things operate within this regulated 00:02:53.669 --> 00:02:55.990 system. Which makes sense. But obviously the 00:02:55.990 --> 00:02:57.830 stakes go up. What about the next level, Class 00:02:57.830 --> 00:03:00.840 2? Right. Class 2 devices. These pose a moderate 00:03:00.840 --> 00:03:03.259 risk. And because the risk is higher, they need 00:03:03.259 --> 00:03:05.340 something more than just general controls. They 00:03:05.340 --> 00:03:07.340 need special control. Special controls. OK. What 00:03:07.340 --> 00:03:09.180 does that mean in practice? Well, it's not a 00:03:09.180 --> 00:03:11.159 single thing. Special controls are tailored to 00:03:11.159 --> 00:03:13.219 the device type. They might include mandatory 00:03:13.219 --> 00:03:16.419 performance standards, special labeling requirements 00:03:16.419 --> 00:03:19.300 to ensure safe use, maybe rules about post -market 00:03:19.300 --> 00:03:22.639 surveillance, tracking how the device performs 00:03:22.639 --> 00:03:24.439 out in the real world. And they often have to 00:03:24.439 --> 00:03:27.060 follow specific FDA guidance documents too. So 00:03:27.060 --> 00:03:29.759 extra requirements specific to the device layered 00:03:29.759 --> 00:03:32.020 on top of the basics. What are some examples 00:03:32.020 --> 00:03:34.379 of class two devices? Good examples would be 00:03:34.379 --> 00:03:37.979 certain diagnostic tests like Colliaglycine test 00:03:37.979 --> 00:03:40.780 systems for liver issues or chymotrypsin tests 00:03:40.780 --> 00:03:43.560 for pancreatic problems. Also things like CPAP 00:03:43.560 --> 00:03:46.120 machines, positive airway pressure delivery systems 00:03:46.120 --> 00:03:48.520 for sleep apnea. Those are class two. And it 00:03:48.520 --> 00:03:50.620 can get really specific. Take HIV diagnostic 00:03:50.620 --> 00:03:53.000 tests like the HIV NAT tests. They're class two, 00:03:53.199 --> 00:03:55.159 but they require incredibly detailed labeling 00:03:55.159 --> 00:03:57.919 plus extensive of analytical and clinical performance 00:03:57.919 --> 00:04:00.580 data. That detail is the special control. Gotcha. 00:04:00.659 --> 00:04:03.180 That makes sense. So that leaves Class 3. The 00:04:03.180 --> 00:04:06.020 top of the pyramid. High risk. What defines these? 00:04:06.180 --> 00:04:09.539 Class 3 is for the highest risk devices. We're 00:04:09.539 --> 00:04:11.719 talking devices that support or sustain human 00:04:11.719 --> 00:04:14.259 life. Or they're super important in preventing, 00:04:14.259 --> 00:04:16.579 you know, serious health impairment. Or they 00:04:16.579 --> 00:04:19.160 just present a potential unreasonable risk of 00:04:19.160 --> 00:04:21.160 illness or injury. And because the risk is so 00:04:21.160 --> 00:04:23.660 high? They always require the most stringent 00:04:23.660 --> 00:04:27.980 review pathway, pre -market approval, PMA, no 00:04:27.980 --> 00:04:30.660 exceptions. This is really the FDA's highest 00:04:30.660 --> 00:04:33.300 bar for proving safety and effectiveness. I imagine 00:04:33.300 --> 00:04:35.660 the examples here are pretty critical devices. 00:04:36.040 --> 00:04:38.160 Absolutely. Think about things like absorbable 00:04:38.160 --> 00:04:40.939 hemostatic agents or dressings used in surgery 00:04:40.939 --> 00:04:43.939 to stop bleeding fast or certain types of artificial 00:04:43.939 --> 00:04:46.660 hip joints. These are explicitly called out as 00:04:46.660 --> 00:04:49.199 needing PMA before they can be sold. The potential 00:04:49.199 --> 00:04:51.420 impact on a patient is just too significant to 00:04:51.420 --> 00:04:53.600 rely on anything less. The stakes are definitely 00:04:53.600 --> 00:04:55.939 highest here. Okay, so that classification system 00:04:55.939 --> 00:04:58.839 based on risk seems pretty clear. Class 1, 2, 00:04:58.839 --> 00:05:02.519 3, general controls, special controls, PMA. Now 00:05:02.519 --> 00:05:05.079 the big question for manufacturers, how do you 00:05:05.079 --> 00:05:07.220 actually get your device to the market? Let's 00:05:07.220 --> 00:05:09.620 talk pathways. Starting with the 510K, that seems 00:05:09.620 --> 00:05:13.079 really common for Class 2. It is. The 510K pre 00:05:13.079 --> 00:05:16.339 -market notification is the main route for most 00:05:16.339 --> 00:05:18.800 Class 2 devices, and even some Class I devices 00:05:18.800 --> 00:05:21.980 that aren't exempt. The whole point of a 510K 00:05:21.980 --> 00:05:25.019 is for the manufacturer to show the FDA that 00:05:25.019 --> 00:05:27.579 their new device is substantially equivalent 00:05:27.579 --> 00:05:30.040 to a device that's already legally on the market. 00:05:30.660 --> 00:05:32.639 And that existing device has a name. It's called 00:05:32.639 --> 00:05:35.639 the predicate device. Substantial equivalence. 00:05:35.660 --> 00:05:38.220 That sounds like the key phrase here. What does 00:05:38.220 --> 00:05:40.680 the FDA actually look for? How do they define 00:05:40.680 --> 00:05:42.759 that? Right. It boils down to two main criteria. 00:05:42.959 --> 00:05:45.800 First, the new device has to have the exact same 00:05:45.800 --> 00:05:48.360 intended use as the Predicate device it's being 00:05:48.360 --> 00:05:50.899 compared to. And second, it needs to either have 00:05:50.899 --> 00:05:52.899 the same technological characteristics as the 00:05:52.899 --> 00:05:55.740 Predicate, or if the tech is different, maybe 00:05:55.740 --> 00:05:57.699 different materials, a new design feature, different 00:05:57.699 --> 00:05:59.740 energy source, whatever the manufacturer has 00:05:59.740 --> 00:06:03.439 to provide data. And that data, potentially including 00:06:03.439 --> 00:06:05.500 clinical data if the FDA thinks it's needed, 00:06:06.019 --> 00:06:08.420 has to prove the new device is just as safe and 00:06:08.420 --> 00:06:10.860 effective as the predicate. Ah, okay. So it doesn't 00:06:10.860 --> 00:06:13.459 have to be identical, just equivalent in safety 00:06:13.459 --> 00:06:15.720 and effectiveness for that specific use. Exactly. 00:06:15.839 --> 00:06:17.899 It's not about being a carbon copy. You know, 00:06:18.000 --> 00:06:20.540 that concept, a substantial equivalence, it feels 00:06:20.540 --> 00:06:23.160 like a really practical approach. Without it, 00:06:23.379 --> 00:06:26.079 imagine every tiny tweak, every slightly different 00:06:26.079 --> 00:06:29.120 material or software update needing years of 00:06:29.120 --> 00:06:31.860 clinical trials. It could really slow down innovation. 00:06:32.060 --> 00:06:34.439 That's a great point. It allows for safe iteration 00:06:34.439 --> 00:06:38.060 and improvement without... starting from scratch, 00:06:38.199 --> 00:06:40.019 every single time. And I bet the paperwork for 00:06:40.019 --> 00:06:42.699 this is intense. Documentation must be key. Oh, 00:06:42.839 --> 00:06:45.060 absolutely critical. The design history file, 00:06:45.199 --> 00:06:48.860 the DHF, is hugely important for a 510K. Think 00:06:48.860 --> 00:06:51.899 of the DHF as the device's biography. From the 00:06:51.899 --> 00:06:54.139 first concept sketch, through all the design 00:06:54.139 --> 00:06:56.980 changes, the testing, the validation. It all 00:06:56.980 --> 00:06:58.579 has to be in there. It's the proof of the design 00:06:58.579 --> 00:07:00.399 process, showing you follow design controls, 00:07:00.959 --> 00:07:04.019 verify the design, validate it. If it's not documented 00:07:04.019 --> 00:07:06.959 in the DHF, regulatorily speaking, it didn't 00:07:06.959 --> 00:07:09.139 happen. Makes sense. Record -keeping is paramount. 00:07:09.540 --> 00:07:11.680 Okay, but what about those Class 3 devices, the 00:07:11.680 --> 00:07:13.139 high -spakes ones we talked about? They don't 00:07:13.139 --> 00:07:16.139 use 510k. They need pre -market approval, PMA. 00:07:16.339 --> 00:07:18.819 How different is that process? Oh, it's a world 00:07:18.819 --> 00:07:22.399 of difference. PMA is, hands down, the most stringent 00:07:22.399 --> 00:07:25.069 review pathway. reserved only for those Class 00:07:25.069 --> 00:07:27.910 3 devices. The review itself happens in stages, 00:07:28.050 --> 00:07:30.230 and it's incredibly thorough. It starts with 00:07:30.230 --> 00:07:32.610 an administrative review. Basically, the FDA 00:07:32.610 --> 00:07:35.329 checks if the application is even complete, if 00:07:35.329 --> 00:07:37.209 it meets all the requirements in the regulations, 00:07:37.290 --> 00:07:40.870 like Section 814 .20. They're pretty strict. 00:07:41.209 --> 00:07:43.230 They could actually refuse to even file the PMA 00:07:43.230 --> 00:07:45.769 if it's missing stuff, or, interestingly, if 00:07:45.769 --> 00:07:48.689 you also have a 510K pending for the same device. 00:07:48.910 --> 00:07:50.910 Okay, so a gatekeeping check first. Then what? 00:07:50.910 --> 00:07:53.560 Then comes the deep dive. the scientific review. 00:07:54.220 --> 00:07:56.879 This is where FDA experts meticulously pour over 00:07:56.879 --> 00:07:59.040 all the data to evaluate the device's safety 00:07:59.040 --> 00:08:01.459 and effectiveness. And manufacturers have to 00:08:01.459 --> 00:08:03.439 provide extensive data. We're usually talking 00:08:03.439 --> 00:08:05.759 data from large, well -controlled clinical trials 00:08:05.759 --> 00:08:08.540 plus other relevant studies. It's a massive undertaking 00:08:08.540 --> 00:08:11.439 for the company. Years of work, often huge expense. 00:08:11.779 --> 00:08:13.720 You really have to prude your case with solid 00:08:13.720 --> 00:08:15.839 scientific evidence. And isn't there usually 00:08:15.839 --> 00:08:18.100 an advisory committee involved too? Maybe a public 00:08:18.100 --> 00:08:21.990 meeting? Yes, often there is. For many PMAs, 00:08:22.089 --> 00:08:24.449 the FDA sends the application, or key parts of 00:08:24.449 --> 00:08:27.509 it, to an independent advisory committee. These 00:08:27.509 --> 00:08:29.730 committees are made up of outside experts. They 00:08:29.730 --> 00:08:32.110 review the data, often discuss it in a public 00:08:32.110 --> 00:08:34.230 meeting, and then give their recommendations 00:08:34.230 --> 00:08:37.710 back to the FDA. It adds another layer of scrutiny 00:08:37.710 --> 00:08:40.429 and transparency. And then the final decision. 00:08:40.610 --> 00:08:43.750 Right. The FDA makes the final regulatory decision. 00:08:43.950 --> 00:08:46.210 If they approve it, they issue an official PMA 00:08:46.210 --> 00:08:48.830 approval order. Sometimes that approval comes 00:08:48.830 --> 00:08:51.330 with conditions. like requiring specific changes 00:08:51.330 --> 00:08:54.269 to the labeling. And importantly, the approval 00:08:54.269 --> 00:08:56.929 is made public. There's usually a notice and 00:08:56.929 --> 00:08:59.169 a summary of the safety and effectiveness data 00:08:59.169 --> 00:09:01.429 available for anyone to see. That transparency 00:09:01.429 --> 00:09:04.169 is good. What if something goes wrong after a 00:09:04.169 --> 00:09:06.970 PMA device is approved? The FDA has tools for 00:09:06.970 --> 00:09:09.070 that, too. If they get information suggesting 00:09:09.070 --> 00:09:11.470 a device might be causing serious harm or death, 00:09:11.970 --> 00:09:14.129 they can actually initiate a regulatory hearing. 00:09:14.269 --> 00:09:16.529 The outcome of that hearing could be in order 00:09:16.529 --> 00:09:19.509 to temporarily suspend the PMA approval. It's 00:09:19.509 --> 00:09:21.950 a serious measure for urgent public health protection. 00:09:22.470 --> 00:09:24.210 OK, that covers the high -risk path. But what 00:09:24.210 --> 00:09:27.049 about new types of devices, stuff that's innovative, 00:09:27.250 --> 00:09:29.889 maybe low or moderate risk, but there's just 00:09:29.889 --> 00:09:32.629 nothing like it already on the market? No predicate 00:09:32.629 --> 00:09:36.330 device exists, so a 510K isn't possible. But 00:09:36.330 --> 00:09:38.669 maybe it's not risky enough for a full PMA. What 00:09:38.669 --> 00:09:41.039 happens then? That's exactly where the de novo 00:09:41.039 --> 00:09:43.299 pathway comes in. It's designed specifically 00:09:43.299 --> 00:09:47.279 for that situation. It's for novel, low -to -moderate 00:09:47.279 --> 00:09:49.840 risk devices where there's no existing predicate. 00:09:50.379 --> 00:09:52.799 Essentially, it allows the FDA to classify a 00:09:52.799 --> 00:09:55.840 totally new type of device and set the requirements 00:09:55.840 --> 00:09:58.740 for it. If the manufacturer meets the criteria, 00:09:59.220 --> 00:10:01.700 the FDA grants the de novo request, creating 00:10:01.700 --> 00:10:04.019 a new classification and clearing the way for 00:10:04.019 --> 00:10:06.899 the device. It stops new, lower -risk tech from 00:10:06.899 --> 00:10:08.899 getting stuck. That's smart. Keeps innovation 00:10:08.899 --> 00:10:11.230 moving. Now, what about devices before they even 00:10:11.230 --> 00:10:12.909 get to any of these pathways, when they're still 00:10:12.909 --> 00:10:15.629 being tested, maybe in clinical trials? Ah, right. 00:10:15.850 --> 00:10:18.549 That's governed by Investigational Device Exemptions, 00:10:18.710 --> 00:10:23.330 or IDEs. That's under 21 CFR Part A -12. An approved 00:10:23.330 --> 00:10:26.070 IDE basically gives permission to ship and use 00:10:26.070 --> 00:10:28.450 a device for clinical investigation purposes, 00:10:29.049 --> 00:10:31.409 even if it would normally need a PMA or meet 00:10:31.409 --> 00:10:34.200 some other standard. It's essential for gathering 00:10:34.200 --> 00:10:36.639 the clinical data you need for a future PMA or 00:10:36.639 --> 00:10:39.139 maybe even a 510 -K without breaking the rules 00:10:39.139 --> 00:10:41.460 before it's approved. And I assume there are 00:10:41.460 --> 00:10:43.679 different levels of scrutiny for these trials, 00:10:44.139 --> 00:10:47.379 too. Yes, definitely. The FDA distinguishes between 00:10:47.379 --> 00:10:50.240 significant risk and non -significant risk device 00:10:50.240 --> 00:10:52.720 studies. Studies with significant risk devices 00:10:52.720 --> 00:10:55.379 generally need formal IDE approval directly from 00:10:55.379 --> 00:10:57.779 the FDA, plus approval from an institutional 00:10:57.779 --> 00:11:01.200 review board, or IRB, at the study site. For 00:11:01.200 --> 00:11:03.039 non -significant risk studies, you might only 00:11:03.039 --> 00:11:05.419 need the IRB approval, assuming you meet certain 00:11:05.419 --> 00:11:07.379 conditions and label the device correctly for 00:11:07.379 --> 00:11:09.600 investigational use. But even if it's investigational, 00:11:09.779 --> 00:11:12.120 quality still matters, right? Absolutely critical. 00:11:12.259 --> 00:11:14.820 Even devices under an IDE must comply with design 00:11:14.820 --> 00:11:16.899 controls, part of that quality system regulation 00:11:16.899 --> 00:11:18.980 we mentioned earlier. It just highlights that 00:11:18.980 --> 00:11:22.059 good quality engineering, careful design, proper 00:11:22.059 --> 00:11:24.639 documentation is required throughout the entire 00:11:24.639 --> 00:11:27.000 device lifecycle from the very beginning, even 00:11:27.000 --> 00:11:29.559 in the lab. through clinical trials and into 00:11:29.559 --> 00:11:32.480 manufacturing. Patient safety and data integrity 00:11:32.480 --> 00:11:36.039 depend on it. Okay, we've covered a lot. Classifications, 00:11:36.580 --> 00:11:40.960 pathways like 500k, PMA, de novo, IDEs. Let's 00:11:40.960 --> 00:11:43.460 zoom out a bit. Why should you, our listener, 00:11:43.720 --> 00:11:46.220 really care about all these, you know, sometimes 00:11:46.220 --> 00:11:48.539 arcane sounding regulations? Well, at the end 00:11:48.539 --> 00:11:50.840 of the day, it all comes back to one thing. patient 00:11:50.840 --> 00:11:53.480 safety and device effectiveness. Every single 00:11:53.480 --> 00:11:55.480 one of these rules, the classification system, 00:11:55.659 --> 00:11:57.720 the pre -market reviews, even things we haven't 00:11:57.720 --> 00:11:59.600 detailed as much like post -market surveillance 00:11:59.600 --> 00:12:02.899 under Part 822 where the FDA tracks devices after 00:12:02.899 --> 00:12:05.340 launch. It's all fundamentally about making sure 00:12:05.340 --> 00:12:07.539 the medical devices you encounter, the ones doctors 00:12:07.539 --> 00:12:10.039 use, the ones maybe implanted in you or a loved 00:12:10.039 --> 00:12:13.100 one, are actually safe and that they work, that 00:12:13.100 --> 00:12:14.519 they do what they're supposed to do effectively. 00:12:14.679 --> 00:12:16.519 So they're not just bureaucratic hoops, they're 00:12:16.519 --> 00:12:18.820 the safety net, the invisible shield working 00:12:18.820 --> 00:12:21.379 for us. Exactly. And for the manufacturers, the 00:12:21.379 --> 00:12:23.259 absolute foundation for all of this is having 00:12:23.259 --> 00:12:25.940 a solid quality management system or QMS. We 00:12:25.940 --> 00:12:29.240 mentioned 21 CFR Part 820, the quality system 00:12:29.240 --> 00:12:31.519 regulation. That's the core of it in the U .S. 00:12:31.600 --> 00:12:34.899 Internationally, you hear about ISO 13485. This 00:12:34.899 --> 00:12:37.720 QMS isn't just like paperwork, it's the whole 00:12:37.720 --> 00:12:40.159 system for ensuring quality from how you design 00:12:40.159 --> 00:12:42.379 the device, source materials, manufacture it, 00:12:42.379 --> 00:12:45.360 test it, handle complaints. everything. If you 00:12:45.360 --> 00:12:47.659 don't have a compliant QMS, you can face serious 00:12:47.659 --> 00:12:49.720 regulatory action. It really forces quality to 00:12:49.720 --> 00:12:51.460 be built in. And I guess that ties back to the 00:12:51.460 --> 00:12:53.399 documentation you mentioned earlier, the DHF 00:12:53.399 --> 00:12:56.919 and other records. Precisely. Documentation is 00:12:56.919 --> 00:12:59.980 the evidence. Things like the device master record 00:12:59.980 --> 00:13:03.019 or DMR, that's the recipe, the blueprint for 00:13:03.019 --> 00:13:05.379 how to build the device consistently. Then the 00:13:05.379 --> 00:13:08.019 device history record, the DHR, that's the proof 00:13:08.019 --> 00:13:10.399 you actually follow the recipe for each batch 00:13:10.399 --> 00:13:12.659 or unit you made. And the design history file, 00:13:12.960 --> 00:13:16.259 the DHF, tracks the whole design journey. Together, 00:13:16.399 --> 00:13:18.440 they are the essential records that prove compliance 00:13:18.440 --> 00:13:21.299 and ensure consistency batch after batch, year 00:13:21.299 --> 00:13:24.000 after year. It's the story of the device written 00:13:24.000 --> 00:13:26.320 down. You got it. If it wasn't written down from 00:13:26.320 --> 00:13:28.519 a regulatory standpoint, it might as well have 00:13:28.519 --> 00:13:30.539 not happened. Now, we've obviously focused heavily 00:13:30.539 --> 00:13:33.659 on the US FDA system. Is this unique to the US, 00:13:33.679 --> 00:13:36.049 or do we see similar ideas globally? That's a 00:13:36.049 --> 00:13:37.909 really important question, especially for companies 00:13:37.909 --> 00:13:40.629 today. While every country or region has its 00:13:40.629 --> 00:13:43.629 own specific regulations, there are global efforts 00:13:43.629 --> 00:13:45.970 towards harmonization, and you definitely see 00:13:45.970 --> 00:13:48.970 similar concepts. Take the European Union, for 00:13:48.970 --> 00:13:51.129 example. Their medical device regulation, the 00:13:51.129 --> 00:13:54.429 EU MDR, also uses a risk -based classification 00:13:54.429 --> 00:13:57.909 system. Similar idea. But, and this is key, the 00:13:57.909 --> 00:14:00.789 details can differ. There are, as one source 00:14:00.789 --> 00:14:03.169 put it, subtle differences in classification 00:14:03.169 --> 00:14:05.840 rules. So a device that's maybe a sterile class 00:14:05.840 --> 00:14:08.480 Y in Europe might actually be bumped up to class 00:14:08.480 --> 00:14:11.039 two in the U .S. Ah, so it's not a perfect one 00:14:11.039 --> 00:14:13.940 -to -one match. Not always. Which means manufacturers 00:14:13.940 --> 00:14:16.120 who want to sell globally have to navigate this 00:14:16.120 --> 00:14:18.580 carefully. They really need to assess their device 00:14:18.580 --> 00:14:20.919 classifications separately for each major region, 00:14:21.120 --> 00:14:23.860 the U .S., Europe, Canada, wherever they plan 00:14:23.860 --> 00:14:26.700 to market. It adds complexity for sure. It's 00:14:26.700 --> 00:14:28.740 this constant interplay between national rules 00:14:28.740 --> 00:14:31.200 and the global nature of the medical device industry. 00:14:31.370 --> 00:14:34.110 Fascinating. So it really is a complex web, isn't 00:14:34.110 --> 00:14:36.490 it? From the simplest bandage to the most advanced 00:14:36.490 --> 00:14:39.210 implant, there's this deep, intricate system 00:14:39.210 --> 00:14:41.409 working behind the scenes. Understanding even 00:14:41.409 --> 00:14:43.850 a bit of this regulatory landscape gives you 00:14:43.850 --> 00:14:45.929 a whole new appreciation for the safeguards that 00:14:45.929 --> 00:14:48.409 are in place for all of us. It really does. It 00:14:48.409 --> 00:14:51.929 shows how much effort goes into balancing innovation 00:14:51.929 --> 00:14:54.779 with ensuring public health and safety. Absolutely. 00:14:54.879 --> 00:14:57.279 It makes you think about that little symbol or 00:14:57.279 --> 00:14:59.100 marking on a medical device differently, knowing 00:14:59.100 --> 00:15:01.740 the journey it represents. So thinking ahead, 00:15:01.940 --> 00:15:04.340 as technology just keeps accelerating, we're 00:15:04.340 --> 00:15:06.580 seeing more complex devices, maybe more connected 00:15:06.580 --> 00:15:09.639 devices, AI -driven devices. What new challenges 00:15:09.639 --> 00:15:11.960 do you think these FDA Pathways classification, 00:15:12.179 --> 00:15:15.220 510K, PMA, de novo might face in the future? 00:15:15.600 --> 00:15:17.919 How do they keep balancing that need for rapid 00:15:17.919 --> 00:15:20.100 innovation with rigorous patient safety?